ChemoMouthpiece, LLC raises $900K under Reg D
How this compares
- Among 4,693 fund launches filed from DE in the same window it is larger than 63%; the DE median is $500K.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-11-13 | D | $900K | 1 | |
| 2026-10-30 | D | $400K | 3 | −$500K |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Chemomouthpiece on EDGAR
Earlier and related filings by the same issuer and sponsor.
People on the filing
| Shlomo Dov Lehrman | Director |
| Jeffrey Schwab | Director |
| David Yoskowitz | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by David Yoskowitz, President and Manager.
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.